Staphylococcal Infection
📧 Sign up to get email alerts when something new happens for Staphylococcal Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections
The study examining the clinical relevance of intracellular Staphylococcus in bone and joint infections has completed.
-
EMA approval · 2025-11-21EMA Authorised: Invanz (ertapenem sodium) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Invanz (ertapenem sodium) by Merck Sharp & Dohme B.V. for a range of infections including community…
-
FDA approval · 2025-05-13FDA Approved: MUPIROCIN — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals, Inc.'s original application for mupirocin topical antibiotic (generic mupirocin).
-
FDA approval · 2021-11-16FDA Approved: MUPIROCIN — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' original ANDA for mupirocin topical ointment, authorizing its marketing as a generic antibiotic fo…
-
CLINICAL_TRIALS withdrawal · 2021-05-03Clinical Trial Update: Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children [Phase 4]
A Phase 4 study evaluating intravenous immunoglobulins for toxic shock syndromes in children was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus [Phase 2]
Phase 2 clinical trial evaluating treatment of uncomplicated skin and soft tissue infections caused by community-associated MRSA has complet…
-
FDA approval · 2016-01-05FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for a generic mupirocin product (ANDA 090480).
-
FDA approval · 2015-11-18FDA Approved: MUPIROCIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA has approved a supplemental application for mupirocin from Sun Pharmaceutical Industries, Inc., signaling an approved change related to …
-
CLINICAL_TRIALS trial_result · 2014-10-29Clinical Trial Update: Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection [Phase 4]
Phase 4 trial assessing mupirocin ointment to eradicate nasal carriage of Staphylococcus aureus in individuals with HIV infection; status in…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty [Phase 4]
This Phase 4 trial updates the comparison of rifampin-containing combination therapy versus monotherapy for early Staphylococcal prosthetic …
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections [Phase 4]
Phase 4 trial comparing cephalexin to clindamycin for suspected CA-MRSA skin infections; results have been posted (2013).
-
FDA approval · 2013-01-24FDA Approved: MUPIROCIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for mupirocin topical antibiotic, enabling a generic version to be marketed. The approval confirms the…
-
CLINICAL_TRIALS research · 2012-06-26Clinical Trial Update: Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection [Phase 2]
A Phase 2 clinical trial evaluating daptomycin combined with rifampin for treating staphylococcal prosthetic joint infections; current statu…